Dave Barta
Analyst · Capital One. Please go ahead
Thanks, Andrew. As I discussed our segment results, I will again make comparisons to sequential quarterly performance. So starting with the contract operations segment, revenue increased 1% to $96 million, while gross margin was flat at $61 million, resulting in gross margin percentage of 63%. In the aftermarket services segment, revenue was 14% lower at $26 million, while gross margin of $7 million decreased 7% from the prior quarter. This resulted in a gross margin percentage of 28%, up 200 basis points. As Andrew mentioned, we traditionally see a slight reduction in Q1 in South America due to summer holidays, resulting in decline in repair, maintenance and overhaul projects as well as in transactional part sales. Compared to the same period in 2017, however, AMS revenue was up 17% and gross margin was up 26%. Revenue in the product sales segment was $228 million or 7% higher, while gross margin improved 11% to $27 million, resulting in a gross margin percentage of 12%, up 40 basis points from Q4 and up 330 basis points from a year ago. It was a strong quarter for compression. In fact, net revenue from compression orders was at its highest in terms of dollars since the second quarter of 2015. Revenue for processing and treating orders were also higher sequentially, once again reflecting solid conversion and execution of our backlog. The product revenue split was 93% from North America and 7% from international markets. Andrew noted the improvement in product sales bookings to $193 million. Our product sales backlog was $427 million at the end of Q1 as compared to $461 million at the end of 2017. SG&A expenses were flat at $44 million, as we continued to manage costs while investing in revenue-producing initiatives such as new product development. We also implemented a new revenue recognition accounting standard, ASC 606, in Q1. The impact was not material to revenue or gross margin. However, you will see some changes on the balance sheet, and most notably the capitalization of contract obtainment and fulfillment costs, including demobilization and sales commission cost and the recording other related liabilities associated with contracts within our contract operations segment. Also as part of the adoption of 606, you will find enhanced disclosures in our filings regarding backlog. For the first time, you will find reported backlog for our contract operations segment. The backlog we are reporting is $1.2 billion. It’s important to understand the definition of backlog. Our backlog is an estimate of the amount of revenues expected to be realized in future periods based on executed contracts and does not include any assumption for renewals, no matter how likely that is to occur. Additionally, month-to-month contracts or similar constructs, if any, would be included in the backlog at one months’ worth of value and the backlog will also exclude certain other variable consideration elements. Further details surrounding the adoption of this revenue standard will be included in the Form 10-Q, which will be filed today after the market close. Shifting gears a bit. On April 17, 2018, the company entered into a definitive agreement for the sale of our North America production equipment manufacturing facility and associated inventory to Titan Production Equipment Acquisition, LLC, an affiliate of Castle Harlan, Inc. The sale will not have a material financial impact to the company and allows us to accelerate our growth strategy by focusing as a systems and process company for oil, gas, water and power. The company will continue to manufacture production equipment outside of North America. We will continue to offer our customers complete solutions and gas gathering, processing, treating and compression as well as we will continue offering production equipment in North America through Titan. As you may recall, we mentioned several times last year on our quarterly call that we were undertaking a strategic review of the company’s product and service offerings. The PEQ transaction concludes the product line rationalization efforts, as we’ve now completed multiple transactions, including the sale of the Belleli CPE business and the PEQ services business and the exit of the Belleli EPC business, which has all occurred over the past 2.5 years. We feel that we’re now positioned – well-positioned to offer the products and services to maximize the value we can provide to our customers across oil, gas, water and power applications while providing our investors solid returns. Turning to capital expenditures. In the first quarter, total CapEx was $49 million, driven primarily by investing in growth products in our contract operations segment. Looking at the balance sheet, total debt at the end of the first quarter was $387 million, with undrawn and available credit of $561 million. Our leverage ratio, which is debt-to-adjusted EBITDA as defined in our credit agreement, was 1.8x at the end of Q1 as compared to 1.7x at the end of 2017. Our long-term debt less cash or net debt stood at $369 million, up from $319 million at the end of 2017 and the increase was a result of the investment in growth CapEx. We’re well-positioned with adequate capital to take advantage of the pipeline of opportunities we’ve been discussing. And we continue to make progress with respect to working capital. In fact, working capital as a percent of sales improved again and is 1,000 basis points improvement versus a year ago Q1. I’ll turn now to the outlook we have for Q2. In contract operations, Q2 revenue should be in the low $90 million range, with a gross margin percentage flat to slightly lower than Q1. Lower compression capacity requirements in Latin America in Q2 will temporarily decrease revenue for the quarter. However, we expect to return to a run rate in line with our slightly-higher-than-Q1 levels as we enter the second half of the year. For our aftermarket services business, revenue will improve in Q2, going into the mid to high 20s, as Latin America activity will improve, and the gross margin will be slightly lower than Q1. In our product sales segment, revenue should be flat to Q1 levels, with continued gross margin expansion due to our focus on productivity and cost-out initiatives. SG&A should be between $45 million and $47 million, slightly higher sequentially due to the incremental investments and new product initiatives. Depreciation in the second quarter should be in the low 30s and interest expense should be approximately $9 million. I will add, we are maintaining our full year forecast for CapEx and cash taxes as provided in our Q4 call. I’ll turn the call back over to Andrew.